Association of cyclooxygenase-2 and matrix metalloproteinase-2 expression in human breast cancer

By Sivula Anna  

Breast Cancer Research and Treatment, Vol. 89, Iss. 3, 2005-02 ,pp. : 215-220

Springer Publishing Company

Access to resources Recommend Favorite

Culture of human breast cancer cell line (MDA-MB-231) on fibronectin-coated surface induces pro-matrix metalloproteinase-9 expression and activity

By Maity Gargi  

Tumor Biology, Vol. 32, Iss. 1, 2011-02 ,pp. : 129-138

Springer Publishing Company

Access to resources Recommend Favorite

Enhanced inhibitory effect of the matrix metalloproteinase inhibitor Ro 28-2653 in combination with estramustine and etoposide on the prostate carcinoma in the rat Dunning orthotopic tumor model

By Abramjuk Claudia   Lein Michael   Rothaug Winfried   Krell Hans-Willi   Loening Stefan   Jung Klaus  

Cancer Chemotherapy and Pharmacology, Vol. 59, Iss. 2, 2007-02 ,pp. : 275-282

Springer Publishing Company

Access to resources Recommend Favorite

BreastDefend™ prevents breast-to-lung cancer metastases in an orthotopic animal model of triple-negative human breast cancer

By              

Oncology Reports, Vol. 28, Iss. 4, 2012-01 ,pp. : 1139-1145

Spandidos Publications

Access to resources Recommend Favorite

A matrix metalloproteinase inhibitor, batimastat, retards the development of osteolytic bone metastases by MDA-MB-231 human breast cancer cells in Balb C nu/nu mice

By Lee J.   Weber M.   Mejia S.   Bone E.   Watson P.   Orr W.  

European Journal of Cancer, Vol. 37, Iss. 1, 2001-01 ,pp. : 106-113

Elsevier

Access to resources Recommend Favorite